Sanofi SA (SNY)
47.82
-1.69
(-3.41%)
USD |
NASDAQ |
Nov 14, 16:00
47.82
0.00 (0.00%)
After-Hours: 20:00
Sanofi Gross Profit (Annual): 34.87B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 34.87B |
December 31, 2022 | 33.42B |
December 31, 2021 | 31.85B |
December 31, 2020 | 28.79B |
December 31, 2019 | 28.72B |
December 31, 2018 | 28.63B |
December 31, 2017 | 27.87B |
December 31, 2016 | 26.56B |
December 31, 2015 | 26.57B |
December 31, 2014 | 28.95B |
December 31, 2013 | 27.88B |
December 31, 2012 | 31.96B |
December 31, 2011 | 33.73B |
Date | Value |
---|---|
December 31, 2010 | 32.66B |
December 31, 2009 | 31.89B |
December 31, 2008 | 31.53B |
December 31, 2007 | 29.66B |
December 31, 2006 | 27.52B |
December 31, 2005 | 26.05B |
December 31, 2004 | 14.04B |
December 31, 2003 | 7.482B |
December 31, 2002 | 5.747B |
December 31, 2001 | 4.689B |
December 31, 2000 | 4.177B |
December 31, 1999 | 3.987B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
28.72B
Minimum
2019
34.87B
Maximum
2023
31.53B
Average
31.85B
Median
2021
Gross Profit (Annual) Benchmarks
AstraZeneca PLC | 37.54B |
Eli Lilly and Co | 27.04B |
Pfizer Inc | 33.54B |
Regeneron Pharmaceuticals Inc | 11.30B |
Genfit SA | 30.56M |